Prelude Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Prelude Capital Management’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$83K	Buy
2017 Q3	–	Sell
2017 Q2	$2K	Buy
2017 Q1	–	Sell
2016 Q4	$5K	Buy
2016 Q3	–	Sell
2016 Q2	$0	Buy